"Antimicrobial Drugs Market Summary: According to the latest report published by Data Bridge Market Research, the Antimicrobial Drugs Market The global antimicrobial drugs market size was valued at USD 122.89 billion in 2025 and is expected to reach USD 174.76 billion by 2033, at a CAGR of 4.50% during the forecast period Attaining maximum return on...

The US Food and Drug Administration (FDA) has recently rolled back certain regulatory requirements for lab-developed tests (LDTs), a decision that has sparked renewed discussions about clinical ivermectin studies 2025 usa , patient safety, regulatory accountability, and drug access. While LDTs ​​were previously held to strict FDA oversight standards, the rollback now allows...

Fenbendazole 444 Mg is a widely used antiparasitic medication, primarily known for its effectiveness in treating a variety of worm infections in animals. Belonging to the benzimidazole class of drugs, fenbendazole works by disrupting the energy metabolism of parasites, ultimately leading to their death. It is commonly used in veterinary medicine and has gained attention for its broad-spectrum...

The global veterinary pharmaceutical industry is witnessing substantial growth due to rising awareness regarding animal health and increasing investments in livestock management. Fenbendazole has become an essential antiparasitic medication widely used for treating gastrointestinal parasites in animals, including livestock, companion animals, and poultry. The increasing prevalence of parasitic...

Fenbendazole is a broad-spectrum anthelmintic medication widely used in veterinary medicine to treat parasitic worm infections in animals. Belonging to the benzimidazole class of drugs, Fenbendazole is highly effective against a wide range of gastrointestinal parasites. It is commonly administered in tablet, suspension, or granule form and is trusted by veterinarians for its safety and...

" Myiasis Treatment Market Summary: According to the latest report published by Data Bridge Market Research, the  Myiasis Treatment Market The global myiasis treatment market size was valued at USD 499.72 million in 2024 and is expected to reach USD 738.31 million by 2032, at a CAGR of 5.00% during the forecast period All the statistical data...

The schistosomiasis market is expected to witness considerable growth over the coming years due to the increasing prevalence of parasitic infections, rising awareness regarding neglected tropical diseases, and expanding healthcare initiatives across developing and developed economies. Governments, healthcare organizations, and pharmaceutical companies are focusing on improving disease...